Kasper, James M. http://orcid.org/0000-0003-0169-2603
Smith, Ashley E. http://orcid.org/0000-0001-7156-5533
Miller, Sierra N. http://orcid.org/0000-0002-9490-9041
Ara,
Russell, William K. http://orcid.org/0000-0003-1931-4555
Cunningham, Kathryn A. http://orcid.org/0000-0002-4257-1739
Hommel, Jonathan D. http://orcid.org/0000-0001-8305-3746
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (T32DA07287, T32DA07287, P30DA028821, T32DA07287, R03DA033437)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Cancer Prevention and Research Institute of Texas (RP190682)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR001439, KL2TR001441)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
Article History
Received: 25 February 2021
Revised: 29 October 2021
Accepted: 3 November 2021
First Online: 16 December 2021
Competing interests
: Dr. Cunningham has current research funding from VidaLibreBio, Inc., for research unrelated to this study. Additional authors declare no competing interests.